![]() |
Volumn 36, Issue 12, 1996, Pages 722-725
|
Polypharmacy and the treatment of HIV/AIDS
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACICLOVIR;
ANTIINFECTIVE AGENT;
ANTINEOPLASTIC AGENT;
ANTIVIRUS AGENT;
BLEOMYCIN;
COTRIMOXAZOLE;
DIDANOSINE;
DOXORUBICIN;
DRONABINOL;
ETHAMBUTOL;
FLUCONAZOLE;
FOSCARNET;
INDINAVIR;
INTERFERON;
KETOCONAZOLE;
LAMIVUDINE;
MEGESTROL;
METRONIDAZOLE;
OCTREOTIDE;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
RIFABUTIN;
RIFAMPICIN;
RITONAVIR;
SAQUINAVIR;
STAVUDINE;
UNINDEXED DRUG;
VINBLASTINE;
ZALCITABINE;
ZIDOVUDINE;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ARTICLE;
BONE MARROW SUPPRESSION;
CARDIOTOXICITY;
DRUG INTERACTION;
DRUG USE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LIVER TOXICITY;
NEUROTOXICITY;
PATIENT COMPLIANCE;
PRESCRIPTION;
QUALITY OF LIFE;
SIDE EFFECT;
POLYPHARMACY;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
ANTI-HIV AGENTS;
DRUG INTERACTIONS;
HIV INFECTIONS;
HUMANS;
PATIENT COMPLIANCE;
POLYPHARMACY;
|
EID: 0030445926
PISSN: 10865802
EISSN: None
Source Type: Journal
DOI: 10.1016/S1086-5802(16)30163-2 Document Type: Article |
Times cited : (4)
|
References (17)
|